Multiple system atrophy and lower urinary system

Abstract

Multi sistem atrofisi MSA Parkinson hastalığına benzeyen fakat klinik olarak daha ağır, erken başlayan, morbidite ve mortalitesi daha yüksek bir nörodejeneratif hastalıktır. Hastalığın alt üriner sistem semptomları tüm klinik belirtilerden önce başlayabilir. Hastalık alt üriner sistemi etkileyerek noktüri, pollaküri ve mesanenin inkomplet boşalmasının da aralarında bulunduğu bir çok şikayete neden olduğundan ürolojik açıdan ayrıca önem taşımaktadır. Benign prostat hastalığı BPH ile benzer yaşlarda başladığı için yanlışlıkla şikayetler BPH’ya bağlı zannedilip medikal tedaviye cevap vermeyen obstrüktif bulguları için hasta cerrahiye gidebilir. Bu durum hastaların şikayetlerinin kötüleşmesine, hasta ve hekimin memnuniyetsizliğine neden olabilmektedir. O nedenle ürolog, bazen ilk ve en belirgin şikayetler olan obstrüktif alt üriner sistem şikayetlerinin MSA’ya bağlı olmadığından veya hastada MSA olmadığından emin olmalıdır

Keywords

• Benign prostat hiperplazisi,multisistem atrofisi,Parkinson hastalığı

Multi sistem atrofisi ve alt üriner sistem

Abstract

Multiple system atrophy MSA is similar to Parkinson’s disease but it is more severe, early onset neurodegenerative disease and has a higher morbidity and mortality. The symptoms of the disease for lower urinary system may be seen before symptoms of other systems develope. Because the disease causes a lot of complaints including nocturia, frequency and incomplete emptying of the bladder by means of its degenerative effect on lower urinary system, it has a particular importance for urology. Due to similarities in respect of symptoms and findings to prostatic obstruction, some times the patients may be misdiagnosed as having benign prostatic hyperplasia BPH and consequently undergo prostatic surgery when medical treatment suggested to be inadequate. This event may cause the patients’ complaints worsen and result in distressing outcomes for both patients and urologists. Therefore urologist should be sure if obstructive symptoms that sometimes are the only and preceding symptoms of MSA, resulted from BPH or be sure the patient has no MSA actually

Keywords

• Benign prostate hyperplasia,multiple system atrophy,Parkinson’s disease

References

1. Ziemssen T, Reichmann H. Treatment of dysautonomia in extrapyramidal disorders. Ther Adv Neurol Disord 2010; 3(1): 53-67
2. Scottish Intercollegiate Guidelines Network. Diagnosis and Pharmacological Management of Parkinson’s Disease: a National Clinical Guideline. Edinburgh, Scotland: SIGN; 2010.
3. Quinn NP. Multiple system atrophy: the nature of the be- ast. J Neurol Neurosur Ps. June 1989;(suppl):78–89.
4. Wenning GK, Ben-Shlomo Y, Hughes A, et al. What clini- cal features are most useful to distinguish definite multiple system atrophy from Parkinson’s disease? J Neurol Neuro- sur Ps 2000;68:434–40.
5. Graham JG, Oppenheimer DR. Orthostatic hypotensi- on and nicotine sensitivity in a case of multiple system at- rophy. J Neurol Neurosur Ps 1969;32:28–34.
6. Fowler CJ. Integrated control of lower urinary tract – clini- cal perspective. Brit J Pharmacol 2006;147: 14–24.
7. Wenning GK, Ben-Shlomo Y, Magalha˜es M, et al. Clinical features and natural history of multiple system atrophy: an analysis of 100 cases. Brain. 1994;117:835–45.
8. Albanese A, Colosimo C, Lees AJ, Tonali P. The clinical di- agnosis of multiple system atrophy presenting as pure par- kinsonism. Adv Neurol.1996;69:393–8.

9. Daniel SE. The neuropathology and neurochemistry of multiple system atrophy. In: Bannister R, Mathias CJ, eds. Autonomic failure, 3rd ed. Oxford, Oxford Medical Publi- cations, 1992;564–85.
10. Abrams P, Cardozo L, Fall M et al: The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002; 21: 167-78.
11. Wakabayashi K, Takahashi H. Cellular pathology in mul- tiple system atrophy. Neuropathology 2006;26: 338-45.
12. Yamamoto T, Sakakibara R, Uchiyama T et al. When is Onuf’s nucleus involved in multiple system atrophy? A sphincter electromyography study. J Neurol Neurosur Ps 2005;76:1645–48
13. Roth B, Studer UE, Fowler CJ, Kessler TM. Benign prosta- tic obstruction and parkinson’s disease— Should transu- rethral resection of the prostate be avoided?J Neurol Neu- rosur Ps 2005;76:1645–48.
14. Nicoletti G, Lodi R, Condino F et al. Apparent diffusi- on coefficient measurements of the middle cerebellar pe- duncle differentiate the Parkinson variant of MSA from Parkinson’s disease and progressive supranuclear palsy. Brain 2006; 129: 2679–87
15. Oka H, Yoshioka M, Morita M et al. Reduced cardiac 123i-MIBG uptake reflects cardiac sympathetic dysfuncti- on in Lewy body disease. Neurology 2007;69:1460-5.
16. Pahwa R, Lyons KE. Early diagnosis of Parkinson’s disease: Recommendations fom diagnostic clinical guidelines. Am J Manag Care. 2010;16:94-9
17. Flabeau O, Meissner WG, Tison F. Multiple system at- rophy: current and future approaches to management. Rev. Ther Adv Neurol Disord 2010; 3(4): 249-63
18. Bonnet AM, Pichon J, Vidailhet M et al. Urinary dis- turbances in striatonigral degeneration and Parkinson’s disease: clinical and urodynamic aspects. Mov Disord 1997;12:509-13.
19. Sung JH, Mastri AR, Segal E. Pathology of the Shy- Dra- ger syndrome. J Neuropathol Exp Neurol 1978;38:253-68.
20. Morgan C, Nadelhaft, De Groat WC. Location of bladder preganglionic neurones within the sacral parasympathetic nucleus of the cat. Neurosc Lett 1979;14:189-94.
21. Kirchhof K, Apostolidis AN, Mathias CJ, Fowler CJ. Erec- tile and urinary dysfunction may be the presenting featu- res in patients with multiple system atrophy: a retrospecti- ve study. Int J Impot Res 2003;15:293-8.
22. Chandiramani VA, Palace J, Fowler CJ. How to recognize patients with Parkinsonism who should not have urologi- cal surgery. Br J Urol 1997;80:100-04.
23. Sakakibara R, Hattori T, Uchiyama T et al. Urinary dysfunc- tion and orthostatic hypotension in multiple system at- rophy: which is the more common and earlier manifestati- on? J Neurol Neurosur Ps 2000;68:65–9
24. Sakakibara R, Hattori T, Uchiyama T, Yamanishi T. Vide- ourodynamic and sphincter motor unit potential analyses in Parkinson’s disease and multiple system atrophy. J Neu- rol Neurosur Ps 2001;71:600–6
25. Fowler CJ: Update on the neurology of Parkinson’s disease. Neurourol Urodyn 2007;26: 103-9.
26. Hahn K, Ebersbach G: Sonographic assessment of uri- nary retention in multiple system atrophy and idiopathic Parkinson’s disease. Mov Disord 2005; 20:1499-502.
27. Kirby RS, Fowler CJ, Gosling J, Bannister R. Urethro- vesical dysfunction in progressive autonomic failure with multiple system atrophy. J Neurol Neurosur Ps 1986; 49:554–62.
28. Wenning GK, Scherfler C, Granata R, et al. Time course of symptomatic orthostatic hypotension and urinary inconti- nence in patients with postmortem confirmed parkinsoni- an syndromes; a clinicopathological study. J Neurol Neu- rosur Ps 1999;67:620–3.
29. Mannen T, Iwata M, Toyokura Y, et al. The Onuf’s nucleus and the external anal sphincter muscles in amyotrophic la- teral sclerosis and Shy-Drager syndrome. Acta Neuropat- hol 1982;58:255–60.
30. Gilman S, Wenning GK, Low PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Ne- urology 2008;71:670-6.
31. Gama RL, Távora DFG, Bomfim RC et al. Morphometry MRI in the differential diagnosis of parkinsonian syndro- mes. Arq Neuropsiquiatr 2010;68(3):333-8
32. Swan L, Dupont J. Multiple system atrophy. Update. Phys Ther. 1999;79:488–94.
33. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele- Richardson-Olszewski syndrome): re port of the NINDS- SPSP international workshop. Neurology 1996;47:1-9.
34. Pramstaller PP,Wenning GK, Smith SJM, Beck RO, Quinn NP, Fowler CJ. Nerve conduction studies, skeletal musc- le EMG, and sphincter EMG in multiple system atrophy. J Neurol Neurosur Ps 1995;58:618-21
35. Papatsoris A.G., Papapetropoulos S, Singer C, Deliveliotis C. Urinary and erectile dysfunction in multiple system at- rophy (MSA). Neurourol Urodyn 2008; 27: 22-7.
36. Fowler CJ, O’Malley KJ. Investigation and management of neurogenic bladder dysfunction. J Neurol Neurosurg Ps 2003; 74(Suppl 4):27-31.
37. Ito T, Sakakibara R, Yasuda K et al. Incomplete emp- tying and urinary retention in multiple-system atrophy: when does it occur and how do we manage it? Mov Disord 2006;21: 816-23.
38. Sakakibara R, Hattori T, Uchiyama T et al. Are alpha- blockers involved in lower urinary tract dysfunction in multiple system atrophy? A comparison of prazosin and moxisylyte. J Auton Nerv Syst 2000;79:191-5.
39. Sakakibara R, Matsuda S, Uchiyama T,Yoshiyama M, Ya- manishi T, Hattori T. The effect of intranasal desmopres- sin on nocturnal waking in urination in multiple system atrophy patients with nocturnal polyuria. Clin Auton Res 2003;13:106-8.
40. Staskin DS, Vardi Y, Siroky MB: Post-prostatectomy conti- nence in the parkinsonian patient: the significance of poor voluntary sphincter control. J Urol 1988; 140:117-8.
41. Fowler CJ: Neurological disorders of micturition and their treatment. Rev. Brain 1999; 122: 1213-31.